Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Mark Lovell to Chromatography, High Pressure Liquid

This is a "connection" page, showing publications Mark Lovell has written about Chromatography, High Pressure Liquid.

 
Connection Strength
 
 
 
0.130
 
  1. Kelley ZD, Lovell MA, Lynn BC. Pharmacokinetic and metabolic analysis of an Alzheimer's disease therapeutic in rat serum via microfluidic CZE-MS. Biomed Chromatogr. 2022 Jan; 36(1):e5243.
    View in: PubMed
    Score: 0.039
  2. Lovell MA, Xie C, Markesbery WR. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging. 2001 Mar-Apr; 22(2):187-94.
    View in: PubMed
    Score: 0.037
  3. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging. 1997 Sep-Oct; 18(5):457-61.
    View in: PubMed
    Score: 0.029
  4. Liu X, Lovell MA, Lynn BC. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Anal Chem. 2005 Sep 15; 77(18):5982-9.
    View in: PubMed
    Score: 0.013
  5. Wenner BR, Lovell MA, Lynn BC. Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS/MS. J Proteome Res. 2004 Jan-Feb; 3(1):97-103.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)